ar 12456 has been researched along with 5,7-dimethyl-(1,2,4)triazolo(1,5-a)pyrimidine in 1 studies
| Studies (ar 12456) | Trials (ar 12456) | Recent Studies (post-2010) (ar 12456) | Studies (5,7-dimethyl-(1,2,4)triazolo(1,5-a)pyrimidine) | Trials (5,7-dimethyl-(1,2,4)triazolo(1,5-a)pyrimidine) | Recent Studies (post-2010) (5,7-dimethyl-(1,2,4)triazolo(1,5-a)pyrimidine) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 8 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodewei, R; Hering, S; Krause, EG; Schubert, B; Wollenberger, A | 1 |
1 other study(ies) available for ar 12456 and 5,7-dimethyl-(1,2,4)triazolo(1,5-a)pyrimidine
| Article | Year |
|---|---|
Trapidil and other 5-triazolo-(1, 5-alpha)-pyrimidine derivatives as calcium channel blockers in 108CC5 cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Central Nervous System Stimulants; Hybrid Cells; Ion Channels; Mice; Pyrimidines; Rats; Trapidil | 1985 |